NASDAQ · CARLHealthcareSurgical Instruments

Carlsmed, Inc. Common Stock (CARL)

$15.96+10.83%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$15.96▲ 30.61% in range
Nov 3, 2025Low $8.83 · High $16.99Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Carlsmed closed at $15.96 on Nov 4, up 10.83%, 6.1% below its 52-week closing high. Volume of 59.1K shares was 0.79× its 20-day average (below normal).

Split-adjusted performance: +9.0% over one month, +62.2% over six months, +30.6% over one year.

In the quarter ended Jun 30, 2026, revenue was $18.94M, with a net margin of -55.5%.

Short interest was 1.1M shares at the Oct 15 settlement, up 3.9% from the prior report (11.3% of float, 13.6 days to cover).

Market cap$435.8M27.3M shares
Revenue · quarter$18.9M—
Diluted EPS$-0.39—
P/E · TTM—P/S 6.9×
Net margin-55.5%Gross 76.8%
Dividend yieldNone
52-week range8.83 – 16.99−6.1% from high
Volume59.1K0.79× 20-day avg
Volatility · 60d52.0%Annualised
Short % of float11.3%13.6 days to cover
Net cash$73.8MCash $89.2M
Next earnings—Not scheduled
Split-adjusted performance
1W +4.2%1M +9.0%3M +16.5%6M +62.2%YTD +29.2%1Y +30.6%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum88
Revenue growth—
Net margin31
Value (low P/E)—
Size55

Industry medians: 6-month return −4.4%, revenue growth +8.9%, net margin −8.2%, P/E 29.7×.

Short interest

Details →
Shares short1.1M+3.9% vs prior
Days to cover13.6Settled Oct 15
% of float11.3%
Short vol. 10d74.3%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
CARLCarlsmed$15.96+10.83%+62.2%—−55.5%—$435.8M
SIShoulder Innovations$21.14+6.66%+64.0%—−59.1%—$440.1MCompare
SSIISS Innovations International$2.26−2.92%−44.4%+39.4%−19.1%—$453.5MCompare
NPCENeuropace$13.71+11.37%−24.3%+17.1%−27.2%—$470.6MCompare
MDXGMiMedx Group$3.23−0.77%−11.9%−45.2%−13.9%—$470.6MCompare
OFIXOrthofix Medical Inc. Common Stock (DE)$9.63+9.93%−21.0%+3.8%−7.5%—$392.3MCompare
CERSCerus$2.48+5.77%−4.4%+6.3%−0.9%—$498.8MCompare
RCELAvita Medical$16.18+5.54%+266.1%+17.8%−35.3%—$500.4MCompare
EMBCEmbecta$6.62+8.80%+85.8%−8.1%7.8%4.3$374.8MCompare

Quick answers

What does Carlsmed do?
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
What is CARL's market cap?
$435.75M, based on the Nov 4 close of $15.96.
Does Carlsmed pay a dividend?
No regular cash dividend has been paid in the last year.
How much of CARL is sold short?
1.1M shares, 11.3% of float, as of Oct 15, 2026.
What sector is CARL in?
Healthcare, in the Surgical Instruments industry.

About Carlsmed

Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.

HQ: Carlsbad, CA127 employeesListed Jul 23, 2025carlsmed.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology